Clinical status and lung function 10 weeks after severe SARS-CoV-2 infection.
Clinical status and lung function 10 weeks after severe SARS-CoV-2 infection.
复制标题
DOI:
10.1016/j.rmed.2020.106276
复制
发表时间:
2021-01
影响因子:
4.3
通讯作者:
Vanderhelst E
中科院分区:
文献类型:
--
作者:
Smet J;Stylemans D;Hanon S;Ilsen B;Verbanck S;Vanderhelst E
Since studies about clinical status after COVID-19 are scarce, we conducted a cross sectional study with assessment of residual symptoms, lung function and chest CT. During an outpatient follow-up visit, chest CT, pulmonary function and COVID-19 related symptoms were assessed approximately 10 weeks after diagnosis. Demographics, baseline (time of diagnosis) CT score and blood results were collected from patient files. Association between lung function and clinical characteristics (baseline), blood markers (baseline), chest CT (baseline and follow-up) and symptom score (followup) was analysed. Mann-Whitney U tests and Chi squared tests were used for statistical comparison between subgroups with and without restriction. Two hundred-twenty subjects were evaluated at a median follow-up of 74±12 (SD) days. Median symptom and median CT score at follow-up were 1(IQR=0- 2) and 2(IQR=0-6) respectively. Forty-six percent of patients had normal lung function, while TLC and TLCO below the lower limit of normal were observed in 38% and 22% of subjects respectively. This restrictive pulmonary impairment was associated with length of hospital stay (8 vs 6 days; p=0.003), admission to the intensive care unit (27% vs 13%;p=0.009), and invasive mechanical ventilation (10% vs 0.7%;p=0.001), but not with symptom score or CT score at baseline and follow-up. Fifty-four percent of COVID-19 survivors had abnormal lung function 10 weeks after diagnosis. Restriction was the most prevalent pulmonary function, with the more critically ill patients being more prone to this condition. Yet, restriction could not be linked with abnormal imaging results or residual symptoms.
登录
查看更多内容
DOI:
10.1183/09031936.00080312
发表时间:
2012-12
期刊:
The European respiratory journal
影响因子:
--
作者:
Quanjer PH;Stanojevic S;Cole TJ;Baur X;Hall GL;Culver BH;Enright PL;Hankinson JL;Ip MS;Zheng J;Stocks J;ERS Global Lung Function Initiative
通讯作者:
ERS Global Lung Function Initiative
影响因子:
15.1
作者:
Zhao, Yu-miao;Shang, Yao-min;Xu, Ai-guo
通讯作者:
Xu, Ai-guo
影响因子:
24.3
作者:
Verbanck, Sylvia;Van Muylem, Alain;Vincken, Walter
通讯作者:
Vincken, Walter
影响因子:
19.7
作者:
Pan, Feng;Ye, Tianhe;Zheng, Chuansheng
通讯作者:
Zheng, Chuansheng
影响因子:
3.7
作者:
Verbanck, Sylvia;Schuermans, Daniel;Vanderhelst, Eef
通讯作者:
Vanderhelst, Eef